U.S. state-level variation in caregiver-reported provider recommendation of HPV vaccination to 13-to-17-year-old adolescents

INTRODUCTION: Although regional differences in provider recommendation of human papillomavirus (HPV) vaccine have been documented, limited research has examined variation at the state level. Therefore, this study examined state-level differences in caregiver-reported health care provider recommendation of HPV vaccines among 13-to-17-year-old adolescents in the United States. METHOD: Using a cross-sectional design to examine data from the National Immunization Survey-Teen (2023), multivariable logistic regression was used to model state-specific variations in provider recommendation of HPV vaccine. Proportion estimation was used to examine state-specific prevalence. RESULT: Provider recommendation varied considerably across states. For example, the odds of reporting a recommendation were lower among caregivers of adolescents in Arkansas (adjusted odds ratio [AOR] = 0.56, 95% confidence interval [CI] = 0.33 to 0.96), Georgia (AOR = 0.49, 95% CI = 0.26 to 0.93), and Mississippi (AOR = 0.42, 95% CI = 0.24 to 0.74), and higher among caregivers in New Hampshire (AOR = 2.40, 95% CI = 1.23 to 4.68) compared with adolescents in California. Greater heterogeneity was observed in the South compared with other regions. For example, the prevalence of not receiving a recommendation was 16% in Maryland and 41% in Mississippi. CONCLUSION: The findings underscore the need to improve HPV vaccine recommendation in some states in the United States. In particular, states with low rates should be targeted for focused interventions.

Authors

Institutions

Publication Details

Journal
Cancer Causes & Control
Published
2026-11-12
DOI
https://doi.org/10.1007/s10552-026-02283-5
Primary Topic
Cervical Cancer and HPV Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

U.S. state-level variation in caregiver-reported provider recommendation of HPV vaccination to 13-to-17-year-old adolescents

Paula M. Cuccaro, Chinenye Lynette Ejezie, Ming Li, Nada Eldawy et al.
Cancer Causes & Control
Cervical Cancer and HPV Research
article

U.S. state-level variation in caregiver-reported provider recommendation of HPV vaccination to 13-to-17-year-old adolescents

Paula M. Cuccaro, Chinenye Lynette Ejezie, Ming Li, Nada Eldawy, Chengcheng Zhang
article en

Abstract

INTRODUCTION: Although regional differences in provider recommendation of human papillomavirus (HPV) vaccine have been documented, limited research has examined variation at the state level. Therefore, this study examined state-level differences in caregiver-reported health care provider recommendation of HPV vaccines among 13-to-17-year-old adolescents in the United States. METHOD: Using a cross-sectional design to examine data from the National Immunization Survey-Teen (2023), multivariable logistic regression was used to model state-specific variations in provider recommendation of HPV vaccine. Proportion estimation was used to examine state-specific prevalence. RESULT: Provider recommendation varied considerably across states. For example, the odds of reporting a recommendation were lower among caregivers of adolescents in Arkansas (adjusted odds ratio [AOR] = 0.56, 95% confidence interval [CI] = 0.33 to 0.96), Georgia (AOR = 0.49, 95% CI = 0.26 to 0.93), and Mississippi (AOR = 0.42, 95% CI = 0.24 to 0.74), and higher among caregivers in New Hampshire (AOR = 2.40, 95% CI = 1.23 to 4.68) compared with adolescents in California. Greater heterogeneity was observed in the South compared with other regions. For example, the prevalence of not receiving a recommendation was 16% in Maryland and 41% in Mississippi. CONCLUSION: The findings underscore the need to improve HPV vaccine recommendation in some states in the United States. In particular, states with low rates should be targeted for focused interventions.

Cancer Causes & ControlVol. 37(12)
Towson University (US), Florida Atlantic University (US), The University of Texas Health Science Center at Houston (US)
Good health and well-being
Cervical Cancer and HPV Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon